Live Breaking News & Updates on Emory Vaccine Center Srilatha Edupuganti

Emory and NIH continue public-private partnership advancing Alzheimer’s research
The National Institutes of Health is launching the next version of AMP AD (Accelerating Medicines Partnership Alzheimer’s Disease), a public-private partnership that takes an open science, big data approach to identifying biological targets for therapeutic intervention.
The National Institute on Aging will lead research efforts for AMP AD 2.0 and has pledged to contribute $61.4 million over five years. This includes funding six multi-institutional, cross-disciplinary academic research teams, including the team at Goizueta Alzheimer’s Research Center at Emory University, along with a data coordinating center at Sage Bionetworks.
Emory researchers served as a founding academic team for the first iteration of the AMP AD when the initiative began in 2014. Led by Allan Levey and Nicholas T. Seyfried, Emory investigators will play an integral role in AMP AD 2.0 as it seeks to support new t ....

United States , Rollins School , Emory University , Emory University School Of Medicine , Vilma Todri , Scott Lilienfeld , Aliza Wingo , Tom Costello , Ignacio Sanz , Luiz Santos , Laurene Mccullough , Vikas Gupta , Deanna Ferree Womack , Jian Wang , Ahsan Husain , John Hackney , Walter Orenstein , Allen Berger , Tetyana Balyuk , Christopher Scharer , Nawazish Naqvi , Williame Paul , Srikant Rangaraju , Shauna Bowes , Lawrence Boise , Allan Levey ,